2026 NPPES data Hematology & Oncology Physician NPI 1083095848 MD
Verify on CMS →

TEJAS KARAWADIA, MD

Hematology & Oncology Physician in MIDDLEBURG, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 183 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.5963/100
▲ 6 pts above national avg 83.1 · [object Object]
Industry payments
$820.68
43 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

TEJAS KARAWADIA, MD reported a CMS MIPS final score of 89.5963/100 — above the 83.1 national average — and filed 1,262 Medicare Part D claims in 2023.

89.5963/100
MIPS score · +6 vs avg
1K
Part D claims, 2023
76%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

TEJAS KARAWADIA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 42% higher than 58% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

TEJAS KARAWADIA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about TEJAS KARAWADIA, MD?

High performer (top quartile)

NPI registry status

Active

Issued 06/17/2015

NPI 1083095848

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,262 49% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

89.5963/100 6.496300000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Hematology & Oncology Physician compares to other specialties among Florida providers

Florida providers

Hematology & Oncology Physician share within Florida

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Florida

Medicare quality performance — MIPS

TEJAS KARAWADIA, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
89.5963/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 89.5963/100 vs national avg 83.1

0%100%National avg83%89.6%
MIPS final score (Hematology & Oncology Physician) — 89.5963/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TEJAS KARAWADIA, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 1658 ST VINCENTS WAY STE 230, MIDDLEBURG, FL, 32068, with a listed phone of (904) 214-8050. NPI 1083095848 was issued on 06/17/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KARAWADIA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,262 prescription claims written by this provider, covering 183 Medicare beneficiaries and totaling roughly $1.5 million in drug spend, split 24% brand-name and 76% generic by claim count, with an opioid prescribing rate of 21.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.5963/100 for the 2023 performance year, compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1658 ST VINCENTS WAY STE 230
MIDDLEBURG, FL 32068

Provider Details

NPI 1083095848
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 06/17/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.5963
Final Score
Avg: 83.1
84
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where TEJAS KARAWADIA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CANCER SPECIALISTS LLC
MIDDLEBURG, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TEJAS KARAWADIA, MD. Source: openpaymentsdata.cms.gov.

Total received

$821

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to TEJAS KARAWADIA, MD. To verify TEJAS KARAWADIA, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

TEJAS KARAWADIA, MD — brand share 24.0%
Specialty average (est.)

24% brand-name claims vs 76% generic, on 1,262 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,262
Total Claims
$1.5M
Total Drug Cost
183
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,603
Total Day Supply
39,893
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$1.3M
Generic Drug Cost
$129K
Opioid Claims
266 (21.1% rate)
Antibiotic Claims
37

Patient Demographics

Average Patient Age
71.3 years
Avg HCC Risk Score
2.62
Gender Split
63% female / 37% male
Age Distribution
<65: 23, 65-74: 101, 75-84: 47, 85+: 12

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What TEJAS KARAWADIA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Eliquis
Apixaban
201
Oxycodone Hcl
146
Ondansetron Hcl
59
Alprazolam
41
Hydroxyurea
39
Letrozole
39
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
36
Ibrance
Palbociclib
31
Morphine Sulfate Er
Morphine Sulfate
30
Pantoprazole Sodium
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How TEJAS KARAWADIA, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

TEJAS KARAWADIA, MD's 1,262 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as KARAWADIA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TEJAS KARAWADIA, MD's specialty?
TEJAS KARAWADIA, MD specializes in Hematology & Oncology Physician and practices in MIDDLEBURG, Florida. Credentials: MD.
How much does TEJAS KARAWADIA, MD prescribe under Medicare Part D?
In 2023, TEJAS KARAWADIA, MD wrote 1,262 Medicare Part D claims totaling $1.5M in drug costs for 183 beneficiaries.
What is TEJAS KARAWADIA, MD's Medicare quality score?
TEJAS KARAWADIA, MD has a CMS MIPS Final Score of 89.5963/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TEJAS KARAWADIA, MD located?
TEJAS KARAWADIA, MD is located at 1658 ST VINCENTS WAY STE 230, MIDDLEBURG, FL, 32068. Phone: (904) 214-8050.
What is TEJAS KARAWADIA, MD's NPI number?
TEJAS KARAWADIA, MD's National Provider Identifier (NPI) is 1083095848, issued on 06/17/2015.
Does TEJAS KARAWADIA, MD prescribe more brand-name or generic drugs?
TEJAS KARAWADIA, MD's prescribing is 24% brand-name and 76% generic drugs by claim count, with $1.3M in brand drug costs.
Does TEJAS KARAWADIA, MD prescribe opioids?
Yes, TEJAS KARAWADIA, MD had 266 opioid claims in 2023 with an opioid prescribing rate of 21.1%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does TEJAS KARAWADIA, MD prescribe most often?
Based on 2023 Medicare Part D data, TEJAS KARAWADIA, MD's most frequently prescribed drugs include Eliquis, Oxycodone Hcl, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TEJAS KARAWADIA, MD accept Medicare?
TEJAS KARAWADIA, MD appears in CMS Medicare data with 1,262 Part D claims and 183 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TEJAS KARAWADIA, MD's credentials?
TEJAS KARAWADIA, MD's NPI is 1083095848 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology